ELISE Open Call grant funding to Skinive to develop its AI-based solution

Happy to start 2022 by announcing that Skinive has been selected to get through the ELISE AI program – EU-funded European Network of AI Excellence Centres 🎉🥇💶

Thanks to the European Horizon 2020 and ELISE AI network!

Within the framework of the ELISE program, together with a network of artificial intelligence research hubs and scientific advisors, Skinive will improve and develop its solution.  Source

ELISE Open Calls aim to initiate micro-projects to develop novel services and applications of AI to the challenges defined by the project stakeholders. The Open Calls are one of the tools in the ELISE toolbox contributing towards incorporating SMEs and start-ups into their machine learning ecosystem, facilitating and accelerating a broad uptake of machine learning technologies by SMEs and start-ups, as well as ensuring access to machine learning technologies and expertise. The goal is to address the high-impact societal and economic challenges using machine learning.

Learn more about the 1st Open Call: https://elise.fundingbox.com/

Stay tuned to learn more about our progress and results! The ELISE 2nd Open Call is also in the pipeline – make sure to follow us to be the first to know when it is launched!

Skinive Accuracy Report 2021 at Social Science Research Network

Skinive’s accuracy report “Dynamics of the neural network accuracy in the context of modernization of the algorithms of skin pathology recognition” is officially published at Social Science Research Network.

www.ssrn.com

Skinive neural network uses a machine-learning algorithm to calculate the risk rating of skin pathologies. For this study, we used Skinive’s 2020 and 2021 versions trained on 64,000 and 115,000 images respectively. Three validation datasets were used to assess the sensitivity of the algorithm: precancer + cancer, HPV skin pathology, acne, containing 285 images in each set. The specificity has been calculated on a separate validation set containing 6,000 benign neoplasm cases.

The purpose of this study was to estimate the accuracy of Skinive’s algorithm.

We have improved the algorithm to show a statistically significant decrease in the number of neural network errors in determining the risks of skin pathologies.

The results of sensitivity and specificity of the Skinive neural network indicate that the algorithm is highly accurate in detecting various neoplasms and skin diseases. The sensitivity of the Skinive neural network in detecting malignant neoplasms was 89.1% and 95.4% in 2020 and 2021 respectively. The specificity of Skinive’s neural network in determining benign neoplasms was 95.3% in 2020 and 97.9% in 2021. For all skin neoplasms: in 2020, the sensitivity was 95.3%, for specificity 93.5%; in 2021, it was 97.9% and 97.1% respectively.

Download Full Report (PDF): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3974784

Skinive activities and achievements in Autumn 2021

Summing up Skinive’s 2021 activities, we are excited to announce the list of events and conferences Skinive participated in during Autumn 2021:

1. The Next Web Conference (TNW)  (Sep 30 – Oct 01, 2021)

TNW Conference is the most popular tech conference in Amsterdam, a 2-day technology event that brings together international technology executives, policymakers, top-tier investors, scale-ups, and startups for business and knowledge sharing. TNW Conference has grown into one of Europe’s leading technology events and the 15th edition of the conference will bring together 24.500 attendees from all over the world. Visitors include entrepreneurs, developers, marketing managers, CEOs and policymakers.

https://thenextweb.com/conference

The Next Web Conference. Amsterdam, The Netherlands.

Skinive presented its solutions at the corporate stand, and also made a presentation on the stage of the Amsterdam Powerpod. Dozens of participants were interested in Skinive solutions. As a result of the conferences, Skinive found several warm contacts and continued negotiations on further cooperation.

Skinive Solutions at TNW Conference. October, 2021.

The Next Web Conference

Kirill Atstarov – Skinive CEO & Founder at The Next Web Conference

TNW Conference has been running since 2006 and has proven itself as the prime hub that gathers together technology agents driving business innovation.

TNW Conference

Thank you the Startup Amsterdam and Smart Health Amsterdam for the invitation and the opportunity to present Skinive solutions at TNW Conference!

2. World AI Summit (WSAI) (October 13-14, 2021) 

WSAI is the world’s leading and internationally renowned AI summit gathering the global AI ecosystem of Enterprise, BigTech, Startups, Investors and Science, the brightest brains in AI as speakers every year in Amsterdam to tackle head-on the most burning AI issues and set the global AI agenda.

https://worldsummit.ai

World AI Summit 2021. A community of 200,000 InspiredMinds from 167 countries worldwide!

Skinive Solutions at World AI Summit

 

World AI Summit 2021

WSAI. All photos copyright by Skinive

3. Intelligent Health Conference 2021 (October 12, 2021) 

Intelligent Health Conference is the world’s leading AI in Medicine Summit. Intelligent Health is the only large-scale, global summit series focused purely on AI in healthcare and bringing the global AI and health community together to advance discussions on how to apply AI and drive technological collaboration in healthcare.

https://healthcareglobal.com/events/intelligent-health-ai-2021

Intelligent Health Conference

4. Digital Health Meeting (October 7, 2021) 

Digital Health Meeting is a collaboration between DigitalHealthPartners & Smart Health Amsterdam, combining matchmaking and networking.

Digital Health Meeting. Amsterdam, The Netherlands.

Digital Health Meeting. October 7, 2021.

Kirill Atstarov – Skinive CEO & Founder at Digital health meeting

In addition, we are happy to announce that Skinive was selected as a finalist in 2 competitions: eAwards Netherlands 2021 Final Top 10 and Blue Tulip Awards (Health&welness) Top 20

The Blue Tulips Award programme and eAwards Netherlands are competitions that aim to connect innovators, build powerful collaborations and accelerate breakthrough innovations.

eAwards Netherlands 2021 Jury session

eAwards Netherlands 2021

We would like to take this opportunity to show our appreciation for those who made all those amazing events happen!

We are looking forward to new collaborations and opportunities in 2022!

Mole mapping – what is it and how to get your moles mapped?

In a detailed analysis of the requests sent to the Skinive bot, we noticed that people are very often worried not about the condition of a particular mole (pigmented nevus), but the quantity of the moles on their body.  Moreover, with further analysis of the situation, it becomes obvious that there is a fact of special oncological alertness due to the appearance of more and more nevi. Many people see high oncological risks in this. But Is it really so dangerous? Is there a need to urgently visit a dermatologist or an oncologist?

In fact, there are even more options. In certain cases, you can safely stay at home without the risk of missing a serious skin problem. Spoiler alert: all you need to do is download a mobile application and conduct independent monitoring of the skin condition.

It is important to understand: if there are a lot of nevi on the skin, it does not mean that it is time to look for melanoma.  On the other hand, when there are few nevi, this also does not mean that the skin condition can be ignored.

 Indeed, in those people who have a lot of nevi, the risk of melanoma is slightly higher.  And the problem is not even that a malignant transformation of the nevus can occur.  Most often, the danger lies in the appearance of a new skin formation, rather than in the change of an existing one.

But both in the first and in the second case (with a large and small number of nevi) – the most optimal tracking option is to draw up a map of moles (this includes all other types of skin neoplasms), when each nevus, hemangioma, or any other skin pathology is considered in detail and is archived with reference to precise localization on the human body for the possibility of re-analysis and comparison in the future.

Why Mapping Moles?

The key goal of mapping moles is dynamic observation, which allows to timely identify the appearance of new formations on the skin or identify dangerous changes in them.

For people with few moles, mapping helps to notice changes in already existing neoplasms in time. The appearance of new mole in ​​such people, as a rule, is always noticeable without the use of special devices (for example, there was one mole on the forearm, but now there are two: it is easy to notice the difference).  Although there can be problems here, when the nevus appears in a visually inaccessible place (back, buttocks, back of the thighs).

As for people with multiple nevi (usually more than 50), mapping allows solving two main tasks.

  • The first task helps to keep track of the appearance of new pigmented neoplasms since it is quite problematic to do it on your own (for example, there are 7-8 nevi on the forearm, the appearance of another one may not be noticed).
  • The second task allows recording any visual changes in long-standing nevi.  And since there are many nevi, here one cannot do without the help of photographic fixation and mapping.  Moreover, in people with multiple nevi, as a rule, external changes in these neoplasms occur more often.

When and how often is skin mapping required?

Ideally, skin mapping should be done annually. However, if there are triggers, more often. They may include:

  • Active beach season (or any other long stay in the sun, especially with skin burns);
  • Presence of malignant tumors (especially skin, especially melanoma) in the history;
  • Pregnancy;
  • Taking hormonal or immune-inhibiting drugs (immunosuppressants);
  • People whose skin is in long-term contact with potential carcinogens due to professional activity.

And in the case when a person himself suspects the presence of possible dangerous changes in the skin.  The frequency and regularity of mapping in such situations is determined individually at an appointment with a dermatologist or oncologist.

If a person is not in any risk group, it is enough to do mapping once a year in the spring season, before summer, so that later there will be something to compare with (if suddenly after summer there will be changes among skin neoplasms).

In autumn, immediately after the beach season, the mapping may not be informative due to the fact that there may not be any obvious visual changes provoked by the summer sun by this time.

How to do a mole map?

In fact, the process of creating a mole map is quite simple.  Under this term lies a banal photographing of individual areas of the skin, which together should make up the entire body as a whole.  After that, each neoplasm is examined separately for the presence or absence of risks, the exact location, changes in comparison with previous images (if there are archived images) are recorded.

Given the uncomplicated technology, this procedure can be carried out at home using improvised means.  Fortunately, modern mobile phones are equipped with quite good (and sometimes very good) cameras.  Well, or you can use a professional technique.  Processing photos on a PC with an indication of the neoplasms localization should also not be difficult.  In principle, this approach can solve some problems, for example, to fix the appearance of a neoplasm where it did not exist before.  Or, note changes in an already existing neoplasm, but these changes should be sufficiently pronounced (which does not always correspond to the timeliness of seeking medical help).

It is also necessary to understand the presence of a number of other important points:

  •  The process of “home” mapping is not automated, everything is done manually, which requires a lot of time and effort;
  •  The obtained images are not standardized: different distances from the camera to the skin, different lighting, there may be different cameras, different image quality during repeated mapping;
  •  The inability to perform a dermatoscopic image (you can only get a macro photo, a photo of a neoplasm under a magnifying glass is not a dermatoscopy);
  •  Lack of medical opinion.

Taking all this into account, skin mapping should only be trusted by professionals and professional techniques.

Tools for skin lesions mapping.

Usually, mapping of skin neoplasms is performed in health care facilities by specially trained doctors using special equipment.  In the office, there is a stand with one or several cameras that take pictures of a person according to a predetermined algorithm.  Such a device is also equipped with an electronic dermatoscope, with the help of which skin neoplasms are examined in detail under high magnification.  There is also artificial intelligence that helps doctors to make the right decision.  All this information is recorded in the patient’s personal account and stored until the next visit.  Today, this technology is considered the benchmark for skin mapping.

Of course, the reliability and result of such a procedure should not raise any doubts.  But here comes another problem: accessibility.  The cost of such installations is estimated at tens of thousands of dollars, which not every doctor and not every medical center can afford, where dermatological and oncodermatological patients are consulted.  Accordingly, not even in every large city, you can find such a service.  And everyone needs to watch out for skin neoplasms.

An alternative way to perform skin mapping can be dedicated mobile applications for smartphones, such as Skinive.

Download Skinive MD app for iPhone and Android

                               

The main advantages of this approach are accessibility and mobility.

The procedure can be carried out in any office (as opposed to stationary installations, which are tied to a specific office), where there is sufficient lighting and the patient feels comfortable.  The mapping process itself is controlled by artificial intelligence: each neoplasm that the neural network was able to identify is saved and linked to a virtual 3D model of a person.  After the end of the skin scan (also carried out according to a special standardized algorithm, which must be familiarized with before starting the scan), all neoplasms that the neural network previously recognized as potentially dangerous are highlighted for the doctor.  After that, each such neoplasm undergoes a more detailed check with a neural network, on the basis of which the doctor makes his conclusion.  All results are stored in the patient’s personal account and are available for comparison at the next mapping.

It is difficult to disagree with the fact that this approach to compiling a mole map most fully meets modern requirements:

  •  It is not tied to a specific doctor’s office;
  •  Available to a wide range of doctors and institutions;
  •  The results can always be at hand or, if necessary, available to other doctors (joint consultations, patient transfer, training).

Moreover, in order to carry out mapping in this way, special in-depth knowledge in dermatology or dermato-oncology is not always required.  This technique can be considered as a screening test by general practitioners or other non-skin specialists to properly route the patient.

Thus, our health and the health of our skin, in particular, are truly in our hands.

What do doctors think of the Skinive MD app? Survey of the first users.

Interesting fact: according to statistics, 8 out of 10 people make their choice based on reviews. Reviews also help manufacturers improve their products and services based on the specific needs of their audience.

Skinive MD became available on Appstore and Google Play in May 2021. Over 3 months of summer, more than 3000 users from the CIS countries and Europe took part in the open testing of the application.

What do doctors think of the Skinive MD app?

To study the experience of the first users of the application, we conducted an online survey, consisting of 38 questions, covering all the key points of Skinive MD’s work. Separately, we want to thank all survey participants – your feedback allows us to make our applications even better!

Skinive review

Reference: Skinive MD application allows online screening of 45 most common skin diseases without the use of additional equipment. This application is intended for medical professionals of various fields and specialties, as it allows you to solve several multi-level tasks at once (recognition of skin pathology, patient management, increasing medical knowledge in the field of dermatology, and others).

We invite you to familiarize yourself with the survey results in this article. A total of 104 users took part in the survey. Of these, 60.6% are medical workers, of which 51% are directly doctors (general practitioners and dermatologists). 

Skinive review

Figure 1: Structure of Skinive Survey Respondents

Among all respondents, 40.3% use the application on a weekly basis. 

Skinive review

Figure 2: Frequency of Skinive Application Use

Considering the novelty of the application, its specificity and purpose, such use can be regarded as quite frequent. 

More than 95% of the respondents noted the absence of any difficulties at the start of working with the application. 

One of the key functions of the Skinive MD app is to create and manage a patient profile. This makes it possible to store all images of the same patient in one place, and also greatly simplifies the possibility of dynamic observation or to evaluate the effectiveness of the treatment of skin pathology in the same patient in the same area of the body. The need for this function is also indicated by the fact that 56% of survey participants returned to viewing previous skin pathology recognitions in the Skinive MD application.

An important feature of the application is the preservation of the results of the study of skin pathology. Thanks to this, the user has the opportunity to dynamically monitor skin pathology, organize counseling and others. The frequency and reasons for viewing the saved results are shown in the figure:

Skinive review

Figure 3: Frequency and Reasons for Viewing Stored Results in the Skinive App

Thanks to the well-thought-out implementation of the patient profile, more than 80% of the respondents did not have any difficulties when working with this function. Only in a few cases were there any difficulties in finding the created profile or the desired photo in this profile. An insignificant part of the respondents (5.8%) noted the presence of difficulties at the very beginning of working with a patient profile when starting the first check after creating a patient profile.

Regarding the main function of the application – screening of skin pathology using a smartphone camera, then, as expected, users had a few more problems due to the presence of specific settings and features of the application. 56.7% of the respondents noted certain difficulties, among which the most frequent were difficulties with the operation of the 3D model of the human body (27.9%) and additional functions of the “smart” camera of the application (17.3%): AI-assistant and additional illumination to obtain a better and clearer image of skin pathology.

Skinive review

Figure 4: Major Difficulties in Performing Skin Pathology Check in Skinive App

At the same time, the feedback shows that all these difficulties arise only at the first attempt at recognition. Subsequently, during repeated scans, such problems arose significantly less and the screening process itself took less time. 34.6% of the respondents were assisted in the inspection by watching a training video. Also, in the future, the AI-assistant of the camera also simplified the shooting process – this was indicated by 86.5% of users.

Skinive review

Figure 5: Influence of the AI ​​camera on the process of capturing skin pathology in the Skinive application

The results obtained are understandable and practically do not cause difficulties in interpretation – this was noted by 86.5% of the respondents.

During the entire time of using the application, there were practically no critical failures that prevented the continuation of work with the application. Only 3 people reported inadvertent termination of the app and 5 reported an endless download of data that was caused by a failure in their internet connection.

The most relevant pathology for recognition was a group of skin neoplasms (benign neoplasms, precancerous conditions, malignant neoplasms), including those of a viral nature (viral warts, viral papillomas, molluscum contagiosum). 96.1% of the respondents indicated that these particular skin pathologies are most in demand for recognition (most often they were photographed using the Skinive MD application).

Skinive review

Figure 6: The structure of the most popular skin pathology for recognition in the Skinive application

At the same time, the recognition accuracy is assessed as high (89.4% of survey participants indicate rare recognition errors or single inaccuracies).

Skinive review

Figure 7: Evaluating the Accuracy of the Skinive Algorithm According to Users

Despite the relatively large range of recognized nosologies, 58.7% of the respondents left the desire to train the neural network to recognize eczema; 57.7% – recognition of injuries, skin burns, skin bites by insects; 35.6% – urticaria. Other requests include dermatitis and rare syndromes with skin lesions (1-2% each).    

The most relevant application can be for general practitioners – this is the opinion of 73.1% of respondents, for dermatologists – 61.5%, for oncologists – 51% and for pre-doctor’s offices – 47.1%.

Skinive review

Figure 8: Relevance of the Skinive application for doctors of different specialties

Of course, the use of a smartphone by a doctor in the course of clinical practice can have certain negative reactions from the patient. However, correct information about the goals and advantages of this type of research, the absence of any consequences (non-invasive procedure, preservation of medical secrecy, lack of storage of personal information) allows you to minimize the unjustified alertness of patients. Refusals to photograph skin pathology were rare (4.8% of all respondents).

It is also important to note a number of identified shortcomings when using the Skinive MD application. The survey showed that in almost half of the cases, users simply did not know or could not independently find such useful functions as disabling the AI-assistant of the camera (this function is necessary if there are problems with focusing), turning on the backlight (smartphone flashlight) directly in the application, adding comments to result screen or the ability to correct the result if necessary (for example, after receiving the results of a histological examination or other clarifying techniques). 

Skinive review

Figure 9: Important features of the Skinive app that users most often did not know were available

In this regard, the application could not be fully used. In the future, these functions will become more visible, and the quality of information about existing and new application capabilities will also increase.

In general, the Skinive MD application received a fairly high rating from the end and target user – the medical audience. This is evidenced by the fact that 93.3% of users are determined to continue using Skinive MD in their medical practice, and 51% are ready to do it constantly and regularly.

Skinive review

Figure 10: Future Prospects for Skinive MD Application

No less positive is the fact that the overwhelming majority of users (97.1%) would recommend Skinive MD to their colleagues. This once again indicates the trust and the real possibility of using artificial intelligence and the Skinive algorithm in particular in their work.

Download Skinive MD
AppStore and GooglePlay

Skinive has been CE Marked as a medical device

We are pleased to announce that Skinive has received CE Mark clearance in the European Union.

The CE marking confirms that Skinive solutions meet the requirements of the European Medical Devices Directive (MDD). This clearance opens up the market significantly for our solutions. The CE mark covers 27 countries in the European Union. More importantly it validates our AI-powered solution as credible option and gives physicians and patients within the EU access to a reliable tool so they can identify skin conditions in an affordable and accessible manner.

As we stand today, We are proud to say we have achieved this.

Skinive offers disruptive, comprehensive deep-tech diagnostic and monitoring solutions for home and professional use.

We possess an innovative product, based on AI and our own database.

The tool for early-stage diagnostics and monitoring of skin pathologies available for everyone.

“Receiving CE mark reinforces our mission to urgently deliver our technology to patients around the world and we are excited to get started”  Kirill Sokolov, CEO of Skinive Holding.

The device will aid dermatologists, doctors and nurses in obtaining a quick second opinion and improve detection of dermatologic conditions.

It will also bring great value to patients as receiving care in the comfort of their own homes.

Skinive announces participation in the IMCAS Conference & Dermatology Innovation Forum 2021

Skinive announces participation in the upcoming events:

IMCAS World Congress – the world leading congress in dermatology and plastic surgery

Virtual Conference, Date: Jun 30, 2021
IMCAS Congress brings together the latest evidence-based techniques from prominent speakers and the newest developments from major industry players. IMCAS Congresses are medical research conferences focused on providing plastic surgeons and dermatologists with the latest academic and industry updates for their professional progress in the aesthetic field.

EVENT URL: https://www.imcas.com/ru/academy/webinar/imcas-innovation-tank-what-are-the-best-innovations

 

⁃ Dermatology Innovation Forum 2021– Advancing Innovation in Dermatology

Dermatology Innovation ForumVirtual Conference, Date: Jun 26, 2021
The mission of the Dermatology Innovation Forum is to build a leadership community of individuals and organizations who are excited about developing ideas into products that can substantially improve skin health.

Event URL: https://www.advancing-derm.org/events/dermatology-innovation-forum-2021-advancing-innovation-in-dermatology/

We are pleased to present our solution to the leading industry players and share our experience with professionals in the field of dermatology!

Invitation to the International DEBRA Congress 2021 on Epidermolysis Bullosa

We are pleased to announce that Skinive has become an information partner of DEBRA Russia, which is part of the international organization DEBRA International and provides comprehensive assistance to butterfly children diagnosed with epidermolysis bullosa (EB) in Russia and the CIS.

We invite you to the DEBRA Annual International Congress 2021. The Congress will take place online from September 16 to 19, 2021. It is important for us that as many people as possible have access to EB expertise.

We will be glad to see doctors and medical workers, as well as patients at this event. Together, we can bring more attention to EB and help patients see new opportunities.

What awaits you at the DEBRA Congress 2021:

  • Scientific and practical program;
  • Medical seminars, round tables and sessions for healthcare professionals and patients;
  • Access to medical and scientific electronic posters;
  • Submission of abstracts;
  • Participant certificate;
  • Electronic gift.

Special offer for our Skinive users and partners: skinive30 promo code for a 30% discount. There are also group discounts up to 60%. Admission is free for patients.

Registration link >> https://debracongress2021.ru/register

 

Who are butterfly children?

Behind the romantic name lies a serious illness – epidermolysis bullosa. Children suffering from this ailment are called butterfly children, comparing the fragility of their skin to the fragility of a butterfly’s wing.

Epidermolysis bullosa (EB) is a genetic skin disorder in which there is a breakdown in genes that regulate proteins that hold the layers of skin, epidermis, and dermis together.

What is the International DEBRA Congress?

This groundbreaking event will bring together all the world’s knowledge of EB research, clinical treatment and the EB community.

This pooling of the latest knowledge from key stakeholders will not only provide guidance for EB professionals, but will also help develop strategies for the research, regulatory, financial and medical communities.

Which doctors help patients with EB?

Epidermolysis bullosa is a multidisciplinary disease that affects more than just the skin. This means that not only a dermatologist is involved in the treatment.

Here is a list of doctors that a patient with EB should contact for proper therapy and improve the quality of life: pediatrician, geneticist, gastroenterologist, ophthalmologist, cardiologist, nutritionist, otolaryngologist, dentist, surgeon, plastic surgeon, orthopedist, oncologist, psychologist, rehabilitologist.

 

Who should join?

1. Medical professionals.

Our goal is to bring together all the world’s knowledge of epidermolysis bullosa (EB) research and clinical management.

Participation in the Congress is a unique networking opportunity for professionals from all over the world. You will be able to share your experience and get the latest information in the field of EB. And your knowledge will help patients living with EB around the world get advice on care and treatment

2. Patients

Our mission is to improve the lives of people living with epidermolysis bullosa (EB).

DEBRA International Congress 2021 will bring together experts in EB research, clinical treatment and the EB community. And they will all come together to exchange research results and their experiences. Thus, all patients will have access to information about the latest research and international experience in clinical treatment. Each patient will have the opportunity to ask questions and get answers to medical professionals.

It is important for us that as many patients as possible have access to the knowledge of EB and the opportunity to exchange experiences from anywhere in the world. As a patient, you can pre-register on our website absolutely free!

 

Skinive team and organizers of the DEBRA Congress 2021

Skinive: Skin Health Screening Web-Widget Available On Websites!

Our team is pleased to present a new application in the Skinive line – the Skinive Web Widget, based on our API service Skinive.Cloud .

We have a holistic dermatological artificial intelligence that can scan 30 skin conditions: all forms of skin cancer, viral diseases and acne.

Check the accuracy of our algorithm via the Skinive web widget below:

The Skinive Web Widget easily integrates into websites with any CMS-systems, from Tilda and WordPress to custom systems, and searches our image database for matches and returns the name of the skin condition.

Skinive will be able to increase user engagement and conversion in actions for the following categories of sites:

  • Skin Care Websites & Blogs
  • Health Information Sites
  • Telemedicine Platforms
  • Websites of clinics and beauty salons
  • Websites for healthcare professionals
  • Pharmaceutical companies specialized in dermatology
  • Patient Advocacy Sites

Do you want to install the Skinive web widget on your site?

Contact us now for further instructions!

 

Some examples of integration:

  • Yarko – clinic for laser hair removal and cosmetology

Delivering quality: CE mark and ISO 13485 certificate

We are proud to announce that Skinive received ISO-13485 Quality Management System (QMS *) Certificate (integrated with IEC 62304 and ISO 14971) for medical devices and software in December 2020.

Safety and quality are non-negotiable in medical devices, which is why our company’s management system is ISO 13485 certified. ISO 13485 standard is the progressive design, configuration, manufacture, installation and sale of medical devices that are safe for their intended use.

This success is the result of a continuous striving to improve our products and services and could not have been achieved without close collaboration within the company.

ISO-13485 Certificate Skinive

We are looking forward to new opportunities and projects with our old and new partners and clients!

These documents allowed us to obtain an official assessment of the risk class of our product from the European Competent Authority: I under the MDD Directive and IIa under the MDR Regulation. The implementation of ISO 13485 makes it possible to register our mobile application as a medical device in the European Union and receive the CE marking. In the process of developing the QMS, we have developed a user manual taking into account the requirements of the MHRA recommendation, MDR and mobile application labeling.

The ISO 13485 concept is applicable to companies that design, manufacture, and service medical devices. This standard specifies the requirements for a quality management system * that can be used by an organization in performing all stages of the life cycle of a medical device.

The process of implementing the Quality Management System is rather long and complicated, but it carries a number of advantages:

  • expansion of the sales market, since the Standard makes it possible to use our mobile application in all European countries, as well as in a number of other countries;
  • increasing the level of trust from customers;
  • increasing image and competitiveness;
  • the opportunity to participate in public procurement and obtain lucrative contracts.

We applied a clear system of work for each department of our company to allow ourselves to provide quality services to the consumer.

Artem Lian Head of DataScience

Artem Lian

CTO, Head of DataScience

“Considering that we develop software in the field of medicine, it is very important for us to build processes for the further development of the product in accordance with the regulatory requirements of the European Union and the United States. The QMS allows you to track all current regulatory documents through the Regulatory support process. “ – commented Artem Lyan, Skinive co-founder and CTO.

Kirill Atstarov CEO Skinive

Kirill Atstarov

CEO, Co-founder

“The implementation of ISO 13485: 2016 is a key milestone on our journey towards full compliance with global health regulations. We look forward to supporting the global community of dermatologists and skin health professionals with Skinive” – commented Kirill Atstarov, Skinive CEO and Co-founder.

The Skinive quality review was carried out by a team of experts from XportKat, an international consulting company, the QMS audit is planned by a certification body authority based in Czech Republic, Prague.

To learn more about our solutions and benefits, schedule a video call with our experts
https://calendly.com/skinive/

* QMS (quality management system) is a set of processes within an organization aimed at identifying, measuring, controlling, and improving core activities in accordance with customer requirements and regulatory requirements applicable to your organization’s medical devices and related services. Most countries have also recognized international standards published by committees such as the International Organization for Standardization (ISO) as a core requirement for compliance.

Skinive at Rockstart AI Digital Demo Day.

For the past 6 months, we’ve been developing our business in ‘s-Hertogenbosch, the Netherlands, at the beautiful campus of the Jheronimus Academy of Data Science. We’ve been working hard and on March 19th we introduced Skinive to the audience of investors, corporates and program mentors at Rockstart AI Digital Demo Day!

 Jheronimus Academy of Data Science (JADS)

Due to the current situation in the world, it was a remote event with more than 150 attendees and it was a unique experience for us! We would like to thank Eliza, Raymond, Vladimir and all the Rockstart team for putting together a great digital show and for this amazing opportunity!

Happy to announce, that according to the voting results, Skinive was recognized as the most probable startup to make the biggest exit!

Rockstart AI Digital Demo Day voting results.

Sharing knowledge and experience with Amsterdam Medical Data Science.

Nowadays, Artificial Intelligence technology is for sure not lacking of attention in media and academic publications. But how much use is made of the potential of Data Science and innovation in European medical practice? 

On February 18th, 2019, Skinive specialists attended a medical conference linking top-class healthcare professionals and DataScience at the VUmc Cancer Centre in Amsterdam.

amsterdammedicaldatascience.nl

The event was hosted by the Amsterdam Medical Data Science community, Amsterdam UMC, VU University Amsterdam and the University of Amsterdam.

We would especially like to highlight the following reports:

  • Phosphoproteomics for Precision Medicine – Connie Jiminez (Pulmonology, Amsterdam UMC)
  • Deep Generative Modeling for Histopathology Images – Jakub Tomczak (VU, Amsterdam)

It was an excellent opportunity to get valuable tips and get acquainted with the Dutch medical community! 

Our team was very pleased to attend the meeting and would like to thank the organisers for the invitation.

We are looking forward to developing a partnership with the best European experts.

Skinive at the Rockstart AI Ecosystem Day in the Academy of Data Science.

On February 12th, investors, entrepreneurs, mentors, scientists and interested people gathered in the beautiful campus of the Jheronimus Academy of Data Science (JADS) in ‘s-Hertogenbosch (The Netherlands). They hosted the Rockstart AI Ecosystem Day for the 3rd time.

Rockstart AI is an organization supporting artificial intelligence and emerging technology companies and startups in Europe. As such, they organize Ecosystem Days within the domain of AI by bringing together some of the best AI-specialized tech startups and business partners in Europe to talk about industry disruption, challenges and collaboration.

Our team presented Skinive at the Rockstart AI Ecosystem Day and would like to thank Rockstart for the opportunity to pitch Skinive to Corporate partners from KPMG, KPM, ABN-Amro and many more as well as other professionals, mentors and investors! It was an amazing chance to present our product to professionals and we highly appreciate this opportunity to share, learn and connect!

Jheronimus Academy of Data Science. Rockstart AI Ecosystem Day
Kirill Atstarov CEO, Skinive

Skinive participated in Rockstart Health Innovation Day.

On February 4th, Skinive participated in Health Innovation Day in Nijmegen (The Netherlands) organised by Rockstart. This event is to facilitate successful collaborations between innovation managers and experts from different health companies.

It was an amazing opportunity to introduce our product to health care professionals and insurance companies. We are happy to learn more about the industry! Thank you Rockstart for the great experience!

Skinive launched the 3rd edition of the Rockstart acceleration program in the list of top 10 teams!

After weeks of deliberation, Rockstart has finalized the selection and launched its 3rd AI accelerator program, which kicked off last Thursday night in ‘s-Hertogenbosch, the Netherlands. Attendees included mentors, investors as well as other start-ups. These talented entrepreneurs from ten startups across eight different countries will spend the next six months building and refining their products, talking to mentors, and connecting with both potential customers and investors. The first AI program is already showing success with three alumni raising a total of €1.2 million within the first six months after the end of the program, not to mention the vast range of technology collaborations between startups and corporates that have spiraled out from the program.

“We’re excited to welcome startups from all over the world to this third edition of the AI program. Once again, we have a diverse cohort of technology startups utilizing datasets in industries such as healthcare, education, design, database infrastructure, transportation, trading (fiat and crypto), and graphic design – just to name a few,” said Rune Theill, CEO at Rockstart.

As a part of the Rockstart accelerator, startups also gain access to start-of-the-art research, know-how, and talent through Rockstart’s partnership with Jheronimus Academy of Data Science (JADS). JADS is a Master’s and Ph.D. Data Science University focused on intertwining data science with entrepreneurship.

Currently, AI partners, including in-kind, consist of; AWS, Braincreators, Google, IBM Benvalor, Cisco and more. Apart from this strong lineup, startups also have access to Rockstart’s network of experienced mentors, investors, and experts. These mentors will support and guide the startups chosen for this year’s program through the challenges of technology and business development.
“I am thrilled to see the amount and quality of startups who applied for this 3rd accelerator program. Even more excited to announce the ten finalists today. I am confident that each of them will bring a real impact in their respective industries,” said Raymond Alves, AI Program Director at Rockstart.

Read about the Top 10 teams on Rockstart website:

ROCKSTART ANNOUNCES THE TOP 10 STARTUPS FROM THE 3RD EDITION OF THE AI 2019 PROGRAM

Skinive won 1st place at Seedstars Minsk 2019

The final stage of the Belarusian stage of the international startup competition Seedstars World 2019 was held in Minsk. The jury recognized Skinive as the best startup, it is an artificial intelligence platform that can recognize more than 30 of the most common skin diseases.

photo: se

Belarus set a record for the number of applications filed in the region of Central and Eastern Europe and Central Asia: more than 90 startups completed registration forms in English. The most prepared 11 startups were allowed to public defense in the final.

See CEO’s post on Facebook:https://www.facebook.com/malkiel.falcone/posts/2686244798075203908310929533734

Skinive, as a winner, will go to represent Belarus at the regional summit in Nur Sultan, and if successful, at the global summit in Switzerland, where the main prize will be investments of more than $ 500,000.

Seedstars

Seedstars is a Swiss group of companies that holds the competition of the same name in developing countries, invests in the most promising startups and accumulates knowledge and experience of more than 8000 projects.

Skinive is now available in the Doctor Smart app

Doctor Roitberg’s Doctor Smart online medical consultation service, in partnership with the Skinive AI project, has launched a new service – skin scoring based on artificial intelligence (AI). Users can scan their moles (pigmented nevus) in a few seconds by uploading a photo to the application. The neural network will analyze the image and prepare a conclusion whether the formation is dangerous.

Now, users of the Doctor Smart online clinic can now scan their moles (pigmented nevus) using Skinive technology in a few seconds by uploading a photo to the application. The neural network will analyze the image and prepare a conclusion whether the formation is dangerous.

The creation of a health assistant based on neural networks Doctor Smart aims to reduce the burden on doctors and make quality medical services more accessible for users, explained Doctor Smart co-founder Pavel Roitberg:

“We aim to create a multidisciplinary health assistant based on artificial intelligence. Our team, together with partners, develops neural network solutions in the field of medicine, in the future such technologies will help to significantly increase the accuracy and speed of primary diagnostics and reduce operating costs. We see the need of users for high-quality and affordable remote service and plan to launch new products. “

Doctor Smart Team

Recommendations for Skinive AI skin health scoring tests:
● You have a lot of moles on your body, papillomas, genital warts, age spots;
● One of the relatives was ill with melanoma – a high predisposition to skin cancer;
● You spend a lot of time in direct sunlight;
● You noticed an increase in the number of moles, an expansion of the boundaries of age spots.

Skinive.Cloud is a development by WiseAI llc, which determines the pathology of pigmented lesions from images (photo). This is the second product based on medical AI as part of the service. Earlier, Doctor Smart integrated the Care Mentor AI neural network for radiological image analysis. The neural network allows the patient to analyze the study even before the doctor’s appointment or to get a second opinion on the diagnosis already made.

The skin scoring service is already available in the Doctor Smart service – it has no contraindications and you only need a smartphone to receive it. Until the end of August, you can use it for free.

Now Skinive is available for independent developers in the Azure Marketplace!

We are pleased to announce that Skinive is now available on Microsoft Azure Marketplace and we became a part of Microsoft Partner Network!

The Skinive team is open to collaborating with third-party solution developers at DigitalHealth and has announced the publication of its solution in the Azure cloud!

Skinive.Cloud is available to third-party application developers to integrate with web applications, mobile applications and medical systems to improve the quality of skin care users.

The Skinive API service is designed to reduce the problem of the availability of mobile screening tests for end users, as well as for medical professionals: skin care specialists, cosmetologists, general practitioners, and dermatologists.

Additional information is available at: https://shatiko.pp.ua/b2b/

Skinive AI Saved Life at Emerge Conference 2019

On June 4-5, the international IT conference EMERGE was held in Minsk/ Belarus, which gathered more than 2,000 participants from 30 countries. Skinive presented its startup at this conference.

In Belarus doctors diagnose more than 1000 new melanoma cases each year, it means, they detect about 3 cases per day. Today, melanoma was detected not by a doctor, but by our Skinive!

Full HD video Emerge Closing Ceremony & Awards on Voka.tv.

Skinive at the closing ceremony of the Emerge conference

One participant of the conference, out of curiosity, decided to test his skin with the Skinive application, which detected melanoma with a high risk of pre-cancer form. Later, the same day, the doctor confirmed the diagnosis: the disease was detected at an early stage, everything will be fine with the patient and he will get the right treatment on time.

conclusion of dermatoscopy: suspicion of melanoma

Try Skinive to learn about the condition of your skin – just take a photo of the mole with your smartphone and send it to the direct.

For 2 days of the conference we managed to:

  • Check the moles health of more than 200 attendees of the EMERGE (Innovation Tech Conference 2019) and identify one case of skin cancer risk.
  • Check the level of threat of the detected disease at the “Clinical Center of Plastic Surgery and Medical Cosmetology” at Bogdanovicha str., 53 in Minsk, get a referral to a dermatologist.
  • Get the result of the dermatoscopic scan from dermatologist of the skin-venereologic clinic, get a suspected melanoma conclusion and a referral for an oncologist-surgeon consultation.
  • Miraculously scheduled an appointment with the oncologist-surgeon at 21.00 at the end of the working day and had a dermatoscopic screening with FotoFinder.

A biopsy will be done after the dissection and removal of neoplasm.

EMERGE organizers really liked our story, so they told about this case on a big stage during the conference closing ceremony, and also showed our promo video, so now more people will pay attention to their skin health.

Thanks Emerge!

Our journey in 1 year: We grew from a prototype into a finished product that is available to end users.

We are open for API / SDK integration with third-party services and applications developers in #digitalhealth and at the Seed negotiation stage with HealthCare VC’s.

https://emergeconf.io/news/emerge-wrap-up

For the Skinive team, the main victory was a saved human life, as well as loads of positive feedback from new Skinive users with which we were able to communicate in real life!

The First Model With Vitiligo To Be Cast By Victoria’s Secret

Model Chantelle Brown-Young, who goes by the name Winnie Harlow, has walked the runways at New York Fashion Week (NYFW), appeared in ad campaigns, and promoted a message of self-love and body positivity through social media.

But this year, the 24-year-old made history by becoming the first model with vitiligo to be cast by Victoria’s Secret. She’ll walk the runway with the other Victoria’s Secret Angels in November.


Winnie Harlow on Instagram

Loading…

Vitiligo is a condition that causes the loss of skin color in blotches that can appear on any area of the body, including the hair. Harlow has previously made it clear that she is not a vitiligo sufferer, but that she is “a vitiligo model” who is “succeeding.”

And succeeding she has been. She appeared on America’s Next Top Model, gained an Instagram following of millions and had many different modeling opportunities. 

The Toronto native shared an emotional Instagram post after finding out she was cast in the show. In the post, Harlow recalls her nerves during the casting.

“I had a break down before I walked into the most nerve wr[acking] casting of my life,” she recalled. “I asked my driver to go around the block twice before I could walk into the @VictoriasSecret offices so I could re coup [sic].”

Loading…

The model continued that when it came time for her audition she “walked for her life.” She then thanked everyone for their support in her journey. “Thank you for giving me all the energy and kindness in that room … Thank you mommy for praying with me every day for the past three days. And thank you so much to my fans who have been pushing me forward to this point in my career.”

In the video, she breaks down and sobs when she finds out that she has been picked. The moment was especially special as she had tried out for the 2017 Victoria’s Secret Fashion Show but didn’t make the final cut.

In an exclusive interview with Vogue confirming her casting in the latest show, the model discussed diversity and the importance of representation. “Why is there a stigma around being different when we’re all different?” she asked.

“Representation is so important, and I want to [stand for] all women,” she wrote. “Every single woman.”

Loading…

(H/T: PopSugar)

A Plus has reached out to Harlow for comment.

Cover Image via Andrea Raffin / Shutterstock

Hormones Can Change Your Skin Tone

Vitligo pic

VITIGLIO

New hormone-based treatments might be able to treat conditions that alter skin pigment, such as vitiglio

James Heilman, MD via Wikimedia Commons

As far back as the ancient Greeks, people have documented a funny phenomenon among pregnant women: The skin on their faces sometimes changes color. Scientists never quite knew why that happened, though they suspected that it was linked to the spike in the body’s hormones during pregnancy. Now, a new study published this week in eLife found that two sex hormones, estrogen and progesterone, play a key role in regulating the body’s synthesis of melanin, the substance that gives skin pigment.

To test the relationship between hormones and skin pigment, the researchers administered doses of the hormone estrogen to a 3D array of cells designed to mimic the structure of human skin. The longer the cells were exposed to estrogen, the more melanin they produced; after four days, the cells produced up to 300 percent more melanin than before they were exposed to estrogen. The researchers did the same test with progesterone (a synthetic version, progestin, is in oral contraceptives), which the body also produces during pregnancy, and found that cells decreased their melanin production when exposed to that hormone.

That was intriguing, since the melanocytes (the cells that produce melanin) don’t have traditional hormone receptors.

When the researchers took a closer look at the molecular pathways, they discovered that the hormones activate special pathways in the melanocyte cell membranes that tell the cell to create more or less melanin. To test their hypothesis, the researchers eliminated those receptors from the cells and found that the hormones no longer changed how much melanin they produced, as they predicted.

This discovery could lead to treatments for skin pigment conditions such as vitiligo, in which skin loses pigment because melanocytes are destroyed. It could also help researchers develop non-toxic ways to alter skin tone for cosmetic purposes, like making a person look tan without exposure to UV rays or paler without using damaging bleach on the skin.

In fact, the researchers isolated one of the melanin-increasing compounds and applied it as cream to the inside of mice’s ears for three weeks, which visibly darkened their skin. What’s not yet clear is if these sorts of creams would have any side effects—for example, on fertility—if used on humans.

In future studies the researchers hope to investigate more pathways through which hormones can affect cells’ melanin production, according to a press release.

Woman Born With Moles All Over Her Body Is Trying Out for Miss Universe

Evita Delmundo was bullied for years after being born with moles all over her body — now, she’s setting her sights on becoming the next Miss Universe Malaysia.

“It’s always been a dream for me to try out for Miss Universe Malaysia,” she told Elle Malaysia. “I feel likes it’s a good way for me to showcase my uniqueness and newfound confidence, and hopefully I can also inspire others.”

She added: “I think my audition went well, so I’m just hoping to get a callback from the organization soon.”

Delmundo, a 20-year-old from Sabah, didn’t always embrace her unique look. Born with moles spotting her body from head to toe, the woman was ridiculed and often shied away from attention.

“The other kids would call me names like ‘Monster’ or ‘Chipsmore,’ which was really tough to swallow as a young girl,” she said.

But those days are long gone for Delmundo.

“Beauty is not just what’s on the outside; it’s not someone with the perfect face or the perfect body,” she said. “Beauty is who you are as a person and how you love yourself. It’s never about perfection.”

Before becoming the picture of confidence she is today, Delmundo said she initially sought to have her moles removed, only to have doctors tell her it would negatively impact her health.

“So, I just had to accept this is the body I’ve been given,” she told the magazine. “Now I’m grateful I didn’t change anything.”

Delmundo’s Instagram page shows many shots of her smiling and showing off her look with fierce poses and strong facial expressions.

FROM PEN: Christie Brinkley’s Girls Alexa and Sailor Reveal How They’ve Conquered Bullies and Body Shamers Play VideoYOU MIGHT LIKEOPRAH OPENS UP ABOUT HER MOTHER’S DEATH AND THEIR “SACRED AND BEAUTIFUL” GOODBYEAQUAMAN — AND WIFE! JASON MOMOA AND LISA BONET SHARE A KISS ON THE RED CARPET

“Having a beautiful life is you love yourself,” she wrote alongside one photo. “Don’t care what people think of you and just be free yourself.”

She told Elle that she has received an outpouring of support from her massive social media following.

“Some of my Instagram followers have told me that I’m their idol or that they look up to me and see me as an inspiration,” she said. “Knowing that I have such a positive effect on others really keeps me going.”